PMID- 36237491
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20221015
IS  - 1177-5467 (Print)
IS  - 1177-5483 (Electronic)
IS  - 1177-5467 (Linking)
VI  - 16
DP  - 2022
TI  - Quality of Vision After LASIK, PRK and FemtoLASIK: An Analysis Using the Double 
      Pass Imaging System HD AnalyzerTM((R)).
PG  - 3351-3359
LID - 10.2147/OPTH.S373448 [doi]
AB  - PURPOSE: Analyze and compare the quality of vision of Photorefractive keratectomy 
      (PRK), LASER in situ keratomileusis with mechanical microkeratome (LASIK) and 
      femtosecond-assisted LASIK (FS-LASIK) using the double-pass imaging system HD 
      AnalyzerTM((R)). SETTING: Ophthalmology department of Centro Hospitalar 
      Universitario do Porto (CHUPorto). DESIGN: Retrospective, non-randomized, single 
      center study. METHODS: Analysis of three equivalent groups of patients submitted 
      to PRK, LASIK and FS-LASIK at our department. The objective quality of vision 
      assessment included the objective scatter index (OSI), the modular transfer 
      function cutoff frequency (MTF) and the predicted visual acuity within the 100% 
      (PVA), 20% (PVA20) and 9% contrast levels (PVA9) that were evaluated at baseline, 
      1st week, 1 and 6 months after surgery. RESULTS: 118 eyes were included: 40 
      underwent LASIK, 43 FS-LASIK and 35 PRK. The mean age was 30.6+/-4.6 years old and 
      56% were female. There was a significant impact concerning the type of procedure 
      in the objective quality of vision analysis (Repeated measures ANOVA): the 
      FS-LASIK group showed lower OSI values overtime [F(1,2)=4.566, p=0.012, OSI 
      0.83+/-0.53 (FS-LASIK) vs 0.87+/-0.47 (PRK) and 1.21+/-1.44 (LASIK)], higher MTF values 
      [F(1,2)=6.569, p=0.002, MTF 40.17+/-8.33 vs 32.37+/-11.4 (PRK) and 30.26+/-10.28 
      (LASIK)], higher PVA 100% [F(1,2)=10.871, p<0.001], PVA 20% [F(1,2)=9.737, 
      p<0.001] and PVA 9% [F(1,2)=6.335), p=0.003]. CONCLUSION: In our study, FS-LASIK 
      showed an excellent optical performance through the HD AnalyzerTM technology, 
      with significantly lower OSI and higher MTF, PVA100, PVA20 and PVA9 values. 
      According to our results, this procedure seems to be superior to PRK and LASIK 
      regarding visual quality objective parameters.
CI  - (c) 2022 Vieira et al.
FAU - Vieira, Rita
AU  - Vieira R
AUID- ORCID: 0000-0002-5309-6347
AD  - Refractive Surgery Unit of Ophthalmology Department of Centro Hospitalar 
      Universitario do Porto (CHUPorto), Oporto, Portugal.
FAU - Marta, Ana
AU  - Marta A
AUID- ORCID: 0000-0003-3495-4649
AD  - Refractive Surgery Unit of Ophthalmology Department of Centro Hospitalar 
      Universitario do Porto (CHUPorto), Oporto, Portugal.
FAU - Abreu, Ana Carolina
AU  - Abreu AC
AUID- ORCID: 0000-0003-4842-8623
AD  - Refractive Surgery Unit of Ophthalmology Department of Centro Hospitalar 
      Universitario do Porto (CHUPorto), Oporto, Portugal.
FAU - Monteiro, Silvia
AU  - Monteiro S
AUID- ORCID: 0000-0001-5040-6170
AD  - Refractive Surgery Unit of Ophthalmology Department of Centro Hospitalar 
      Universitario do Porto (CHUPorto), Oporto, Portugal.
FAU - Brochado, Maria do Ceu
AU  - Brochado MDC
AUID- ORCID: 0000-0003-2396-952X
AD  - Refractive Surgery Unit of Ophthalmology Department of Centro Hospitalar 
      Universitario do Porto (CHUPorto), Oporto, Portugal.
LA  - eng
PT  - Journal Article
DEP - 20221010
PL  - New Zealand
TA  - Clin Ophthalmol
JT  - Clinical ophthalmology (Auckland, N.Z.)
JID - 101321512
PMC - PMC9553308
OTO - NOTNLM
OT  - HD analyzer
OT  - LASIK
OT  - PRK
OT  - femtosecond-assisted LASIK
OT  - quality of vision
COIS- The authors have no conflict of interest to declare in this work.
EDAT- 2022/10/15 06:00
MHDA- 2022/10/15 06:01
PMCR- 2022/10/10
CRDT- 2022/10/14 02:50
PHST- 2022/05/19 00:00 [received]
PHST- 2022/07/13 00:00 [accepted]
PHST- 2022/10/14 02:50 [entrez]
PHST- 2022/10/15 06:00 [pubmed]
PHST- 2022/10/15 06:01 [medline]
PHST- 2022/10/10 00:00 [pmc-release]
AID - 373448 [pii]
AID - 10.2147/OPTH.S373448 [doi]
PST - epublish
SO  - Clin Ophthalmol. 2022 Oct 10;16:3351-3359. doi: 10.2147/OPTH.S373448. eCollection 
      2022.